Biogen (BIIB) Receivables - Other (2009 - 2023)

Biogen's Receivables - Other history runs 9 years deep, the most recent figure standing at $6.3 million for Q1 2023.

• In Q1 2023, Receivables - Other fell 98.44% year-over-year to $6.3 million; the TTM figure through Mar 2023 stood at $6.3 million (down 98.44% YoY), while the FY2022 annual figure was $2.0 million, down 99.3% from the prior year.
• Receivables - Other was $6.3 million for Q1 2023 at Biogen, up from $2.0 million in the prior quarter.
• In the past five years, Receivables - Other ranged from a high of $402.7 million in Q1 2022 to a low of $1.8 million in Q3 2022.
• Historically, Receivables - Other has averaged $73.9 million across 5 years, with a median of $5.1 million in 2020.
• The sharpest annual moves came in 2021 and 2022: Receivables - Other jumped 5496.08% in 2021, then sank 99.3% in 2022.
• A 5-year view of Receivables - Other shows it stood at $85.0 million in 2019, then sank by 94.0% to $5.1 million in 2020, then surged by 5496.08% to $285.4 million in 2021, then tumbled by 99.3% to $2.0 million in 2022, then jumped by 215.0% to $6.3 million in 2023.
• The last three Receivables - Other figures came in at $6.3 million (Q1 2023), $2.0 million (Q4 2022), and $1.8 million (Q3 2022), per Business Quant data.